The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis

NCT07746843 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Knee Osteoarthritis
Moderate Knee Osteoarthritis

Interventions

DEVICE: 2107 Injection
DEVICE: DUROLANE®

Sponsor

BioRegen Biomedical (Changzhou) Co., Ltd